✦ LIBER ✦

Perfect adherence in taking antiretroviral drugs – role of the doctors

✍ Scribed by Dorota Rogowska-Szadkowska; Sławomir Chlabicz

Book ID: 118654299
Publisher: Termedia Sp. z.o.o.
Year: 2009
Tongue: English
Weight: 76 KB
Volume: 8
Category: Article
ISSN: 1730-1270
DOI: 10.1016/s1730-1270(10)60029-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measuring Adherence to Antiretroviral Tr

Measuring Adherence to Antiretroviral Treatment: The Role of Pharmacy Records of Drug Withdrawals

✍ Gutierrez, Eliana Battaggia; Sartori, Ana Marli Christovam; Schmidt, Ana Lucia; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 217 KB

The Role of HIV Serostatus Disclosure in

The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence

✍ Michael J. Stirratt; Robert H. Remien; Anna Smith; Olivia Q. Copeland; Curtis Do 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 249 KB

Definition and measurement of adherence

Definition and measurement of adherence to antiretroviral drugs in HIV-1-infected patients

✍ Rita Murri; Adriana Ammassari; Andrea De Luca; Antonella Cingolani; Andrea Antin 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 66 KB

Antiretroviral adherence and HIV treatme

Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy

✍ Anita Palepu; Mark W. Tyndall; Ruth Joy; Thomas Kerr; Evan Wood; Natasha Press; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 162 KB

The Role of Antiretrovirals and Drug Res

The Role of Antiretrovirals and Drug Resistance in Vertical Transmission of HIV-1 Infection

✍ BLUMA G. BRENNER; MARK A. WAINBERG 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Overcoming resistance to existing therap

Overcoming resistance to existing therapies in HIV-infected patients: The role of new antiretroviral drugs

✍ Carlo-Federico Perno; Graeme Moyle; Chris Tsoukas; Winai Ratanasuwan; Jose Gatel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract Resistance to available antiretroviral (ARV) agents is of increasing concern, and development of novel agents that address this problem has been identified as a major public health priority. As ARV resistance becomes more prevalent with extended use of existing agents, individuals with